Life Sciences Giant IQHQ Faces Investor Markdowns Amid Sustained Lab Supply Glut

San Diego based IQHQ faces a 30% vacancy crisis and investor markdowns as the life sciences sector struggles with a supply glut and high interest debt.

By: AXL Media

Published: Mar 21, 2026, 7:15 AM EDT

Source: Bisnow

Capital Markdowns and Investment Volatility

The financial outlook for IQHQ has dimmed as major institutional backers, including T. Rowe Price and Bluerock, have lowered the carrying value of their equity stakes. Bluerock, the developer’s largest shareholder with over $700 million in exposure, recently marked down its fund’s shares by 4.4%. More aggressive cuts were seen from Altegris and T. Rowe Price, with some units valued as low as $2.26. This downward revaluation follows nine consecutive quarters of negative returns for the Bluerock Total Income+ Real Estate Fund, which has struggled with a persistent redemption queue and a significant loss in market value since its public listing.

Strategic Rationale and High Stakes Financing

To navigate the current liquidity crunch, IQHQ has turned to high cost rescue capital. In early 2025, the firm secured $900 million from a consortium including Morgan Stanley, followed by a $270 million commitment from Innovative Industrial Properties Inc. in August 2025. This latter deal, featuring a 16.5% coupon and senior priority status, places significant pressure on the common equity holders. While IQHQ leadership maintains that these moves provide the "runway" necessary to wait out the market cycle, the accrual of millions in unpaid interest on payment in kind loans suggests a shrinking margin for error.

The Research and Development District Challenge

The centerpiece of IQHQ’s struggles is the 1.7 million square foot Research and Development District (RaDD) on the San Diego waterfront. Accounting for more than half of the company’s operating portfolio, the $1.9 billion campus has struggled to secure major life sciences anchor tenants since opening in 2024. Currently, the San Diego market is grappling with a 28.6% vacancy rate in the lab sector, a 60% increase year over year. While the developer has successfully signed retail tenants like Equinox, the lack of large scale biotech leases has led to a $915 million construction loan from Bank OZK requiring a two year extension to avoid immediate default.